CG Oncology, Inc. Common stock
General ticker "CGON" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.2B (TTM average)
CG Oncology, Inc. Common stock follows the US Stock Market performance with the rate: 54.9%.
Estimated limits based on current volatility of 2.5%: low 62.41$, high 65.66$
Factors to consider:
- Total employees count: 61 as of 2023
- Current price 20.4% above estimated high
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [27.37$, 54.74$]
- 2026-12-31 to 2027-12-31 estimated range: [21.44$, 44.90$]
Short-term CGON quotes
Long-term CGON plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $1.14MM | $4.04MM |
| Operating Expenses | $115.81MM | $194.81MM |
| Operating Income | $-114.67MM | $-190.77MM |
| Non-Operating Income | $26.63MM | $29.78MM |
| R&D Expense | $82.10MM | $116.64MM |
| Income(Loss) | $-88.04MM | $-161.00MM |
| Profit(Loss)* | $-88.04MM | $-161.00MM |
| Stockholders Equity | $733.38MM | $752.60MM |
| Inventory | $0.00MM | $1.56MM |
| Assets | $754.80MM | $791.59MM |
| Operating Cash Flow | $-78.71MM | $-132.35MM |
| Capital expenditure | $0.23MM | $0.13MM |
| Investing Cash Flow | $-300.76MM | $-245.82MM |
| Financing Cash Flow | $628.28MM | $153.59MM |
| Earnings Per Share** | $-1.41 | $-2.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.